APO Research
Talk to an analyst

APO RESEARCH · REPORT

Tropicamide

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Tropicamide Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

19 December 2025199 pages

Choose your research edition.

Industry ResearchTropicamide Industry Research Report 2026147 pages · $2,950 USDIndustry Growth & TrendsGlobal Tropicamide Industry Growth and Trends Forecast to 2032121 pages · $3,450 USDMarket StructureGlobal Tropicamide Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032199 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Tropicamide Market Outlook and Growth Opportunities 2026202 pages · $4,250 USDMarket Analysis & ForecastGlobal Tropicamide Market Analysis and Forecast 2026-2032208 pages · $4,950 USD

Market perspective

The global Tropicamide market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for Tropicamide is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Tropicamide is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Tropicamide is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Tropicamide is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Tropicamide include Novartis, Watson Laboratories, Wakamoto, Visufarma, Vega Pharma, Unimed Pharma, Thea Pharma, Roemmers and Polfa Warszawa, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Tropicamide market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Tropicamide and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Tropicamide sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Tropicamide market size, projected growth trends, production technologies, key applications, and end-use industries.

Tropicamide Segment by Company

Novartis

Watson Laboratories

Wakamoto

Visufarma

Vega Pharma

Unimed Pharma

Thea Pharma

Roemmers

Polfa Warszawa

Pharma Stulln

Nippon Tenganyaku Kenkyujo

Miza Pharmaceuticals

Laboratorios Sophia

Edol

Dioptic Pharmaceuticals

Chauvin Ankerpharm

Bausch Health

Alcon Laboratories

Akorn

Agepha Pharma

Tropicamide Segment by Type

5mg

10mg

Tropicamide Segment by Application

Hospital

Drug Store

Tropicamide Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Tropicamide market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Tropicamide and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Tropicamide.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Tropicamide market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Tropicamide manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Tropicamide in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Tropicamide in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Tropicamide Industry Trends Table 2. Tropicamide Industry Drivers Table 3. Tropicamide Industry Opportunities and Challenges Table 4. Tropicamide Industry Restraints Table 5. Global Tropicamide Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Tropicamide Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Tropicamide Sales by Manufacturers (K Units) & (2021-2026) Table 8. Global Tropicamide Sales Market Share by Manufacturers Table 9. Global Tropicamide Average Sales Price (US$/Unit) of Manufacturers (2021-2026) Table 10. Global Tropicamide Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Tropicamide Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Tropicamide Manufacturers, Product Type & Application Table 13. Global Tropicamide Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Tropicamide by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of 5mg Table 17. Major Manufacturers of 10mg Table 18. Global Tropicamide Sales by Type 2021 VS 2025 VS 2032 (K Units) Table 19. Global Tropicamide Sales by Type (2021-2026) & (K Units) Table 20. Global Tropicamide Sales by Type (2027-2032) & (K Units) Table 21. Global Tropicamide Sales Market Share by Type (2021-2026) Table 22. Global Tropicamide Sales Market Share by Type (2027-2032) Table 23. Global Tropicamide Revenue by Type 2021 VS 2025 VS 2032 (K Units) Table 24. Global Tropicamide Revenue by Type (2021-2026) & (K Units) Table 25. Global Tropicamide Revenue by Type (2027-2032) & (K Units) Table 26. Global Tropicamide Revenue Market Share by Type (2021-2026) Table 27. Global Tropicamide Revenue Market Share by Type (2027-2032) Table 28. Major Manufacturers of Hospital Table 29. Major Manufacturers of Drug Store Table 30. Global Tropicamide Sales by Application 2021 VS 2025 VS 2032 (K Units) Table 31. Global Tropicamide Sales by Application (2021-2026) & (K Units) Table 32. Global Tropicamide Sales by Application (2027-2032) & (K Units) Table 33. Global Tropicamide Sales Market Share by Application (2021-2026) Table 34. Global Tropicamide Sales Market Share by Application (2027-2032) Table 35. Global Tropicamide Revenue by Application 2021 VS 2025 VS 2032 (K Units) Table 36. Global Tropicamide Revenue by Application (2021-2026) & (K Units) Table 37. Global Tropicamide Revenue by Application (2027-2032) & (K Units) Table 38. Global Tropicamide Revenue Market Share by Application (2021-2026) Table 39. Global Tropicamide Revenue Market Share by Application (2027-2032) Table 40. Global Tropicamide Sales by Region: 2021 VS 2025 VS 2032 (K Units) Table 41. Global Tropicamide Sales by Region (2021-2026) & (K Units) Table 42. Global Tropicamide Sales Market Share by Region (2021-2026) Table 43. Global Tropicamide Sales Forecasted by Region (2027-2032) & (K Units) Table 44. Global Tropicamide Sales Forecasted Market Share by Region (2027-2032) Table 45. North America Tropicamide Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 46. North America Tropicamide Sales by Country (2021-2026) & (K Units) Table 47. North America Tropicamide Sales by Country (2027-2032) & (K Units) Table 48. Europe Tropicamide Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 49. Europe Tropicamide Sales by Country (2021-2026) & (K Units) Table 50. Europe Tropicamide Sales by Country (2027-2032) & (K Units) Table 51. Asia Pacific Tropicamide Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 52. Asia Pacific Tropicamide Sales by Country (2021-2026) & (K Units) Table 53. Asia Pacific Tropicamide Sales by Country (2027-2032) & (K Units) Table 54. South America, Middle East and Africa Tropicamide Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 55. South America, Middle East and Africa Tropicamide Sales by Country (2021-2026) & (K Units) Table 56. South America, Middle East and Africa Tropicamide Sales by Country (2027-2032) & (K Units) Table 57. Global Tropicamide Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 58. Global Tropicamide Revenue by Region (2021-2026) & (US$ Million) Table 59. Global Tropicamide Revenue by Region (2027-2032) & (US$ Million) Table 60. Global Tropicamide Revenue Market Share by Region (2021-2026) Table 61. Global Tropicamide Revenue Market Share by Region (2027-2032) Table 62. Novartis Company Information Table 63. Novartis Business Overview Table 64. Novartis Tropicamide Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 65. Novartis Tropicamide Product Portfolio Table 66. Novartis Recent Development Table 67. Watson Laboratories Company Information Table 68. Watson Laboratories Business Overview Table 69. Watson Laboratories Tropicamide Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 70. Watson Laboratories Tropicamide Product Portfolio Table 71. Watson Laboratories Recent Development Table 72. Wakamoto Company Information Table 73. Wakamoto Business Overview Table 74. Wakamoto Tropicamide Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 75. Wakamoto Tropicamide Product Portfolio Table 76. Wakamoto Recent Development Table 77. Visufarma Company Information Table 78. Visufarma Business Overview Table 79. Visufarma Tropicamide Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 80. Visufarma Tropicamide Product Portfolio Table 81. Visufarma Recent Development Table 82. Vega Pharma Company Information Table 83. Vega Pharma Business Overview Table 84. Vega Pharma Tropicamide Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 85. Vega Pharma Tropicamide Product Portfolio Table 86. Vega Pharma Recent Development Table 87. Unimed Pharma Company Information Table 88. Unimed Pharma Business Overview Table 89. Unimed Pharma Tropicamide Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 90. Unimed Pharma Tropicamide Product Portfolio Table 91. Unimed Pharma Recent Development Table 92. Thea Pharma Company Information Table 93. Thea Pharma Business Overview Table 94. Thea Pharma Tropicamide Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 95. Thea Pharma Tropicamide Product Portfolio Table 96. Thea Pharma Recent Development Table 97. Roemmers Company Information Table 98. Roemmers Business Overview Table 99. Roemmers Tropicamide Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 100. Roemmers Tropicamide Product Portfolio Table 101. Roemmers Recent Development Table 102. Polfa Warszawa Company Information Table 103. Polfa Warszawa Business Overview Table 104. Polfa Warszawa Tropicamide Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 105. Polfa Warszawa Tropicamide Product Portfolio Table 106. Polfa Warszawa Recent Development Table 107. Pharma Stulln Company Information Table 108. Pharma Stulln Business Overview Table 109. Pharma Stulln Tropicamide Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 110. Pharma Stulln Tropicamide Product Portfolio Table 111. Pharma Stulln Recent Development Table 112. Nippon Tenganyaku Kenkyujo Company Information Table 113. Nippon Tenganyaku Kenkyujo Business Overview Table 114. Nippon Tenganyaku Kenkyujo Tropicamide Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 115. Nippon Tenganyaku Kenkyujo Tropicamide Product Portfolio Table 116. Nippon Tenganyaku Kenkyujo Recent Development Table 117. Miza Pharmaceuticals Company Information Table 118. Miza Pharmaceuticals Business Overview Table 119. Miza Pharmaceuticals Tropicamide Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 120. Miza Pharmaceuticals Tropicamide Product Portfolio Table 121. Miza Pharmaceuticals Recent Development Table 122. Laboratorios Sophia Company Information Table 123. Laboratorios Sophia Business Overview Table 124. Laboratorios Sophia Tropicamide Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 125. Laboratorios Sophia Tropicamide Product Portfolio Table 126. Laboratorios Sophia Recent Development Table 127. Edol Company Information Table 128. Edol Business Overview Table 129. Edol Tropicamide Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 130. Edol Tropicamide Product Portfolio Table 131. Edol Recent Development Table 132. Dioptic Pharmaceuticals Company Information Table 133. Dioptic Pharmaceuticals Business Overview Table 134. Dioptic Pharmaceuticals Tropicamide Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 135. Dioptic Pharmaceuticals Tropicamide Product Portfolio Table 136. Dioptic Pharmaceuticals Recent Development Table 137. Chauvin Ankerpharm Company Information Table 138. Chauvin Ankerpharm Business Overview Table 139. Chauvin Ankerpharm Tropicamide Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 140. Chauvin Ankerpharm Tropicamide Product Portfolio Table 141. Chauvin Ankerpharm Recent Development Table 142. Bausch Health Company Information Table 143. Bausch Health Business Overview Table 144. Bausch Health Tropicamide Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 145. Bausch Health Tropicamide Product Portfolio Table 146. Bausch Health Recent Development Table 147. Alcon Laboratories Company Information Table 148. Alcon Laboratories Business Overview Table 149. Alcon Laboratories Tropicamide Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 150. Alcon Laboratories Tropicamide Product Portfolio Table 151. Alcon Laboratories Recent Development Table 152. Akorn Company Information Table 153. Akorn Business Overview Table 154. Akorn Tropicamide Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 155. Akorn Tropicamide Product Portfolio Table 156. Akorn Recent Development Table 157. Agepha Pharma Company Information Table 158. Agepha Pharma Business Overview Table 159. Agepha Pharma Tropicamide Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 160. Agepha Pharma Tropicamide Product Portfolio Table 161. Agepha Pharma Recent Development Table 162. Key Raw Materials Table 163. Raw Materials Key Suppliers Table 164. Tropicamide Distributors List Table 165. Tropicamide Customers List Table 166. Research Programs/Design for This Report Table 167. Authors List of This Report Table 168. Secondary Sources Table 169. Primary Sources List of Figures Figure 1. Tropicamide Product Image Figure 2. Global Tropicamide Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Tropicamide Market Size (2021-2032) & (US$ Million) Figure 4. Global Tropicamide Sales (2021-2032) & (K Units) Figure 5. Global Tropicamide Average Price (US$/Unit) & (2021-2032) Figure 6. Global Top 5 and 10 Tropicamide Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. 5mg Image Figure 9. 10mg Image Figure 10. Global Tropicamide Sales by Type (2021 VS 2025 VS 2032) & (K Units) Figure 11. Global Tropicamide Sales Market Share 2021 VS 2025 VS 2032 Figure 12. Global Tropicamide Sales Market Share by Type (2021-2032) Figure 13. Global Tropicamide Revenue by Type (2021 VS 2025 VS 2032) & (K Units) Figure 14. Global Tropicamide Revenue Market Share 2021 VS 2025 VS 2032 Figure 15. Global Tropicamide Revenue Market Share by Type (2021-2032) Figure 16. Hospital Image Figure 17. Drug Store Image Figure 18. Global Tropicamide Sales by Application (2021 VS 2025 VS 2032) & (K Units) Figure 19. Global Tropicamide Sales Market Share 2021 VS 2025 VS 2032 Figure 20. Global Tropicamide Sales Market Share by Application (2021-2032) Figure 21. Global Tropicamide Revenue by Application (2021 VS 2025 VS 2032) & (K Units) Figure 22. Global Tropicamide Revenue Market Share 2021 VS 2025 VS 2032 Figure 23. Global Tropicamide Revenue Market Share by Application (2021-2032) Figure 24. North America Tropicamide Sales and Growth Rate (2021-2032) & (K Units) Figure 25. North America Tropicamide Sales Market Share by Country (2021-2032) Figure 26. U.S. Tropicamide Sales and Growth Rate (2021-2032) & (K Units) Figure 27. Canada Tropicamide Sales and Growth Rate (2021-2032) & (K Units) Figure 28. Mexico Tropicamide Sales and Growth Rate (2021-2032) & (K Units) Figure 29. Europe Tropicamide Sales and Growth Rate (2021-2032) & (K Units) Figure 30. Europe Tropicamide Sales Market Share by Country (2021-2032) Figure 31. Germany Tropicamide Sales and Growth Rate (2021-2032) & (K Units) Figure 32. France Tropicamide Sales and Growth Rate (2021-2032) & (K Units) Figure 33. U.K. Tropicamide Sales and Growth Rate (2021-2032) & (K Units) Figure 34. Italy Tropicamide Sales and Growth Rate (2021-2032) & (K Units) Figure 35. Netherlands Tropicamide Sales and Growth Rate (2021-2032) & (K Units) Figure 36. Asia Pacific Tropicamide Sales and Growth Rate (2021-2032) & (K Units) Figure 37. Asia Pacific Tropicamide Sales Market Share by Country (2021-2032) Figure 38. China Tropicamide Sales and Growth Rate (2021-2032) & (K Units) Figure 39. Japan Tropicamide Sales and Growth Rate (2021-2032) & (K Units) Figure 40. South Korea Tropicamide Sales and Growth Rate (2021-2032) & (K Units) Figure 41. Southeast Asia Tropicamide Sales and Growth Rate (2021-2032) & (K Units) Figure 42. India Tropicamide Sales and Growth Rate (2021-2032) & (K Units) Figure 43. Australia Tropicamide Sales and Growth Rate (2021-2032) & (K Units) Figure 44. South America, Middle East and Africa Tropicamide Sales and Growth Rate (2021-2032) & (K Units) Figure 45. South America, Middle East and Africa Tropicamide Sales Market Share by Country (2021-2032) Figure 46. Brazil Tropicamide Sales and Growth Rate (2021-2032) & (K Units) Figure 47. South Africa Tropicamide Sales and Growth Rate (2021-2032) & (K Units) Figure 48. Saudi Arabia Tropicamide Sales and Growth Rate (2021-2032) & (K Units) Figure 49. Turkey Tropicamide Sales and Growth Rate (2021-2032) & (K Units) Figure 50. Argentina Tropicamide Sales and Growth Rate (2021-2032) & (K Units) Figure 51. UAE Tropicamide Sales and Growth Rate (2021-2032) & (K Units) Figure 52. Egypt Tropicamide Sales and Growth Rate (2021-2032) & (K Units) Figure 53. Chile Tropicamide Sales and Growth Rate (2021-2032) & (K Units) Figure 54. Global Tropicamide Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 55. Global Tropicamide Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 56. North America Tropicamide Revenue (2021-2032) & (US$ Million) Figure 57. North America Tropicamide Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 58. Europe Tropicamide Revenue (2021-2032) & (US$ Million) Figure 59. Europe Tropicamide Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 60. Asia-Pacific Tropicamide Revenue (2021-2032) & (US$ Million) Figure 61. Asia-Pacific Tropicamide Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 62. South America, Middle East and Africa Tropicamide Revenue (2021-2032) & (US$ Million) Figure 63. South America, Middle East and Africa Tropicamide Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 64. Tropicamide Value Chain Figure 65. Manufacturing Cost Structure Figure 66. Tropicamide Production Mode & Process Figure 67. Direct Comparison with Distribution Share Figure 68. Distributors Profiles Figure 69. Years Considered Figure 70. Research Process Figure 71. Key Executives Interviewed

Scope & coverage.

Types
  • 5mg
  • 10mg
Applications
  • Hospital
  • Drug Store
Companies covered
  • Novartis
  • Watson Laboratories
  • Wakamoto
  • Visufarma
  • Vega Pharma
  • Unimed Pharma
  • Thea Pharma
  • Roemmers
  • Polfa Warszawa
  • Pharma Stulln
  • Nippon Tenganyaku Kenkyujo
  • Miza Pharmaceuticals
  • Laboratorios Sophia
  • Edol
  • Dioptic Pharmaceuticals
  • Chauvin Ankerpharm
  • Bausch Health
  • Alcon Laboratories
  • Akorn
  • Agepha Pharma

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Tropicamide Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Tropicamide Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Tropicamide Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Tropicamide Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Tropicamide Market Dynamics
  1. 2.1 Tropicamide Industry Trends
  2. 2.2 Tropicamide Industry Drivers
  3. 2.3 Tropicamide Industry Opportunities and Challenges
  4. 2.4 Tropicamide Industry Restraints
3 Tropicamide Market by Manufacturers
  1. 3.1 Global Tropicamide Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Tropicamide Sales by Manufacturers (2021-2026)
  3. 3.3 Global Tropicamide Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Tropicamide Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Tropicamide Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Tropicamide Manufacturers, Product Type & Application
  7. 3.7 Global Tropicamide Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Tropicamide Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Tropicamide Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Tropicamide Tier 1, Tier 2, and Tier 3
4 Tropicamide Market by Type
  1. 4.1 Tropicamide Type Introduction
  2. 4.1.1 5mg
  3. 4.1.2 10mg
  4. 4.2 Global Tropicamide Sales by Type
  5. 4.2.1 Global Tropicamide Sales by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Tropicamide Sales by Type (2021-2032)
  7. 4.2.3 Global Tropicamide Sales Market Share by Type (2021-2032)
  8. 4.3 Global Tropicamide Revenue by Type
  9. 4.3.1 Global Tropicamide Revenue by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global Tropicamide Revenue by Type (2021-2032)
  11. 4.3.3 Global Tropicamide Revenue Market Share by Type (2021-2032)
5 Tropicamide Market by Application
  1. 5.1 Tropicamide Application Introduction
  2. 5.1.1 Hospital
  3. 5.1.2 Drug Store
  4. 5.2 Global Tropicamide Sales by Application
  5. 5.2.1 Global Tropicamide Sales by Application (2021 VS 2025 VS 2032)
  6. 5.2.2 Global Tropicamide Sales by Application (2021-2032)
  7. 5.2.3 Global Tropicamide Sales Market Share by Application (2021-2032)
  8. 5.3 Global Tropicamide Revenue by Application
  9. 5.3.1 Global Tropicamide Revenue by Application (2021 VS 2025 VS 2032)
  10. 5.3.2 Global Tropicamide Revenue by Application (2021-2032)
  11. 5.3.3 Global Tropicamide Revenue Market Share by Application (2021-2032)
6 Global Tropicamide Sales by Region
  1. 6.1 Global Tropicamide Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Tropicamide Sales by Region (2021-2032)
  3. 6.2.1 Global Tropicamide Sales by Region (2021-2026)
  4. 6.2.2 Global Tropicamide Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Tropicamide Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Tropicamide Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Tropicamide Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Tropicamide Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Tropicamide Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Tropicamide Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Tropicamide Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Tropicamide Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Tropicamide Revenue by Region
  1. 7.1 Global Tropicamide Revenue by Region
  2. 7.1.1 Global Tropicamide Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Tropicamide Revenue by Region (2021-2026)
  4. 7.1.3 Global Tropicamide Revenue by Region (2027-2032)
  5. 7.1.4 Global Tropicamide Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Tropicamide Revenue (2021-2032)
  8. 7.2.2 North America Tropicamide Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Tropicamide Revenue (2021-2032)
  11. 7.3.2 Europe Tropicamide Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Tropicamide Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Tropicamide Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Tropicamide Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Tropicamide Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 Novartis
  2. 8.1.1 Novartis Company Information
  3. 8.1.2 Novartis Business Overview
  4. 8.1.3 Novartis Tropicamide Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Novartis Tropicamide Product Portfolio
  6. 8.1.5 Novartis Recent Developments
  7. 8.2 Watson Laboratories
  8. 8.2.1 Watson Laboratories Company Information
  9. 8.2.2 Watson Laboratories Business Overview
  10. 8.2.3 Watson Laboratories Tropicamide Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Watson Laboratories Tropicamide Product Portfolio
  12. 8.2.5 Watson Laboratories Recent Developments
  13. 8.3 Wakamoto
  14. 8.3.1 Wakamoto Company Information
  15. 8.3.2 Wakamoto Business Overview
  16. 8.3.3 Wakamoto Tropicamide Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Wakamoto Tropicamide Product Portfolio
  18. 8.3.5 Wakamoto Recent Developments
  19. 8.4 Visufarma
  20. 8.4.1 Visufarma Company Information
  21. 8.4.2 Visufarma Business Overview
  22. 8.4.3 Visufarma Tropicamide Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Visufarma Tropicamide Product Portfolio
  24. 8.4.5 Visufarma Recent Developments
  25. 8.5 Vega Pharma
  26. 8.5.1 Vega Pharma Company Information
  27. 8.5.2 Vega Pharma Business Overview
  28. 8.5.3 Vega Pharma Tropicamide Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Vega Pharma Tropicamide Product Portfolio
  30. 8.5.5 Vega Pharma Recent Developments
  31. 8.6 Unimed Pharma
  32. 8.6.1 Unimed Pharma Company Information
  33. 8.6.2 Unimed Pharma Business Overview
  34. 8.6.3 Unimed Pharma Tropicamide Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Unimed Pharma Tropicamide Product Portfolio
  36. 8.6.5 Unimed Pharma Recent Developments
  37. 8.7 Thea Pharma
  38. 8.7.1 Thea Pharma Company Information
  39. 8.7.2 Thea Pharma Business Overview
  40. 8.7.3 Thea Pharma Tropicamide Sales, Price, Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Thea Pharma Tropicamide Product Portfolio
  42. 8.7.5 Thea Pharma Recent Developments
  43. 8.8 Roemmers
  44. 8.8.1 Roemmers Company Information
  45. 8.8.2 Roemmers Business Overview
  46. 8.8.3 Roemmers Tropicamide Sales, Price, Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Roemmers Tropicamide Product Portfolio
  48. 8.8.5 Roemmers Recent Developments
  49. 8.9 Polfa Warszawa
  50. 8.9.1 Polfa Warszawa Company Information
  51. 8.9.2 Polfa Warszawa Business Overview
  52. 8.9.3 Polfa Warszawa Tropicamide Sales, Price, Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Polfa Warszawa Tropicamide Product Portfolio
  54. 8.9.5 Polfa Warszawa Recent Developments
  55. 8.10 Pharma Stulln
  56. 8.10.1 Pharma Stulln Company Information
  57. 8.10.2 Pharma Stulln Business Overview
  58. 8.10.3 Pharma Stulln Tropicamide Sales, Price, Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Pharma Stulln Tropicamide Product Portfolio
  60. 8.10.5 Pharma Stulln Recent Developments
  61. 8.11 Nippon Tenganyaku Kenkyujo
  62. 8.11.1 Nippon Tenganyaku Kenkyujo Company Information
  63. 8.11.2 Nippon Tenganyaku Kenkyujo Business Overview
  64. 8.11.3 Nippon Tenganyaku Kenkyujo Tropicamide Sales, Price, Revenue and Gross Margin (2021-2026)
  65. 8.11.4 Nippon Tenganyaku Kenkyujo Tropicamide Product Portfolio
  66. 8.11.5 Nippon Tenganyaku Kenkyujo Recent Developments
  67. 8.12 Miza Pharmaceuticals
  68. 8.12.1 Miza Pharmaceuticals Company Information
  69. 8.12.2 Miza Pharmaceuticals Business Overview
  70. 8.12.3 Miza Pharmaceuticals Tropicamide Sales, Price, Revenue and Gross Margin (2021-2026)
  71. 8.12.4 Miza Pharmaceuticals Tropicamide Product Portfolio
  72. 8.12.5 Miza Pharmaceuticals Recent Developments
  73. 8.13 Laboratorios Sophia
  74. 8.13.1 Laboratorios Sophia Company Information
  75. 8.13.2 Laboratorios Sophia Business Overview
  76. 8.13.3 Laboratorios Sophia Tropicamide Sales, Price, Revenue and Gross Margin (2021-2026)
  77. 8.13.4 Laboratorios Sophia Tropicamide Product Portfolio
  78. 8.13.5 Laboratorios Sophia Recent Developments
  79. 8.14 Edol
  80. 8.14.1 Edol Company Information
  81. 8.14.2 Edol Business Overview
  82. 8.14.3 Edol Tropicamide Sales, Price, Revenue and Gross Margin (2021-2026)
  83. 8.14.4 Edol Tropicamide Product Portfolio
  84. 8.14.5 Edol Recent Developments
  85. 8.15 Dioptic Pharmaceuticals
  86. 8.15.1 Dioptic Pharmaceuticals Company Information
  87. 8.15.2 Dioptic Pharmaceuticals Business Overview
  88. 8.15.3 Dioptic Pharmaceuticals Tropicamide Sales, Price, Revenue and Gross Margin (2021-2026)
  89. 8.15.4 Dioptic Pharmaceuticals Tropicamide Product Portfolio
  90. 8.15.5 Dioptic Pharmaceuticals Recent Developments
  91. 8.16 Chauvin Ankerpharm
  92. 8.16.1 Chauvin Ankerpharm Company Information
  93. 8.16.2 Chauvin Ankerpharm Business Overview
  94. 8.16.3 Chauvin Ankerpharm Tropicamide Sales, Price, Revenue and Gross Margin (2021-2026)
  95. 8.16.4 Chauvin Ankerpharm Tropicamide Product Portfolio
  96. 8.16.5 Chauvin Ankerpharm Recent Developments
  97. 8.17 Bausch Health
  98. 8.17.1 Bausch Health Company Information
  99. 8.17.2 Bausch Health Business Overview
  100. 8.17.3 Bausch Health Tropicamide Sales, Price, Revenue and Gross Margin (2021-2026)
  101. 8.17.4 Bausch Health Tropicamide Product Portfolio
  102. 8.17.5 Bausch Health Recent Developments
  103. 8.18 Alcon Laboratories
  104. 8.18.1 Alcon Laboratories Company Information
  105. 8.18.2 Alcon Laboratories Business Overview
  106. 8.18.3 Alcon Laboratories Tropicamide Sales, Price, Revenue and Gross Margin (2021-2026)
  107. 8.18.4 Alcon Laboratories Tropicamide Product Portfolio
  108. 8.18.5 Alcon Laboratories Recent Developments
  109. 8.19 Akorn
  110. 8.19.1 Akorn Company Information
  111. 8.19.2 Akorn Business Overview
  112. 8.19.3 Akorn Tropicamide Sales, Price, Revenue and Gross Margin (2021-2026)
  113. 8.19.4 Akorn Tropicamide Product Portfolio
  114. 8.19.5 Akorn Recent Developments
  115. 8.20 Agepha Pharma
  116. 8.20.1 Agepha Pharma Company Information
  117. 8.20.2 Agepha Pharma Business Overview
  118. 8.20.3 Agepha Pharma Tropicamide Sales, Price, Revenue and Gross Margin (2021-2026)
  119. 8.20.4 Agepha Pharma Tropicamide Product Portfolio
  120. 8.20.5 Agepha Pharma Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Tropicamide Value Chain Analysis
  2. 9.1.1 Tropicamide Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Tropicamide Production Mode & Process
  6. 9.2 Tropicamide Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Tropicamide Distributors
  9. 9.2.3 Tropicamide Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst